Clinical decision-support only. For use by licensed dental professionals. Not a substitute for professional judgment or a complete drug reference. Always verify with primary sources.
← Back to search
Medication

Repaglinide

Antihyperglycemic (meglitinide)

Brand names: Prandin

Oral health effects

  • Hypoglycemia risk (meal-timed)

    Rapid-acting insulin secretagogue taken with meals; hypoglycemia if a meal is skipped.

    Clinical management: Confirm the patient ate; keep glucose available.

  • Indirect periodontal/caries risk via glycemic control

    These agents do not act directly on the mouth, but the underlying diabetes (and how well it is controlled) strongly influences periodontal disease, healing, and infection risk.

    Clinical management: Reinforce that good glycemic control supports periodontal health; coordinate care and note HbA1c.

Sources

  1. Adverse drug events in the oral cavity. Yuan A, Woo SB. Oral surgery, oral medicine, oral pathology and oral radiology, 2015.